Year archive

AprilBio Co.,Ltd. — 2024 filings

All 38 regulatory filings released by AprilBio Co.,Ltd. (397030) in 2024, sourced directly from the official regulator.

38 Filings

2024 Period

2024 filings (38)

Filing	Released	Lang
주주명부폐쇄기간또는기준일설정 Notice of Dividend Amount	2024-12-17	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-12-10	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-12-04	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-11-27	Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차) Capital/Financing Update	2024-11-21	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-11-19	Korean
분기보고서 (2024.09) Interim / Quarterly Report 9M 2024	2024-11-14	Korean
기업설명회(IR)개최 Report Publication Announcement	2024-11-08	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-10-21	Korean
전환청구권행사 (제1회차) Share Issue/Capital Change	2024-10-02	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2024-09-11	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-09-11	Korean
기업설명회(IR)개최 Report Publication Announcement	2024-09-10	Korean
반기보고서 (2024.06) Interim / Quarterly Report H1 2024	2024-08-12	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2024-08-02	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-07-19	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-07-19	Korean
투자판단관련주요경영사항 (자가염증질환 치료제 APB-R3 기술이전 계약체결) M&A Activity	2024-06-20	Korean
투자판단관련주요경영사항(임상시험결과) (자가염증질환 치료제 APB-R3 제1상 임상시험결과) Legal Proceedings Report	2024-06-07	Korean
분기보고서 (2024.03) Interim / Quarterly Report Q1 2024	2024-05-14	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2024-04-30	Korean
불성실공시법인지정 (공시불이행) Legal Proceedings Report	2024-04-29	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-04-22	Korean
기업설명회(IR)개최 Report Publication Announcement	2024-04-11	Korean
불성실공시법인지정예고 (공시불이행) Regulatory Filings	2024-04-04	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2024-03-20	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2024-03-20	Korean
감사보고서제출 Audit Report / Information FY 2023	2024-03-12	Korean
사업보고서 (2023.12) Audit Report / Information FY 2023	2024-03-12	Korean
투자판단관련주요경영사항(임상시험결과) (자가염증질환 치료제 APB-R3 제1상 임상시험 Topline data 수령) Legal Proceedings Report	2024-03-07	Korean
주주총회소집공고 AGM Information	2024-03-05	Korean
[기재정정]주주총회소집결의 AGM Information	2024-03-05	Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2023	2024-03-05	Korean
주주총회소집결의 AGM Information	2024-02-27	Korean
기업설명회(IR)개최 Report Publication Announcement	2024-02-16	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2023	2024-02-06	Korean
전환가액의조정(제1회차) Capital/Financing Update	2024-01-22	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2024-01-22	Korean